Multi-centric Castleman's Disease: Clinical Trials

1 trial for Multi-centric Castleman's Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Multi-centric Castleman's Disease: new trials by email Literature Review of Multi-centric Castleman's Disease trials Research Report on Multi-centric Castleman's Disease

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase III Trial of VDJ001 In Patients With Idiopathic Multicentric Castleman Disease
Recombinant Humanized Anti-Interleukin-6 Receptor Monoclonal Antibody Injection, Placebo - Anti IL-6R, Castleman's Disease, Multicentric
Phase 3RecruitingBeijing VDJBio Co., LTD.452025-01-272026-10-13

Sponsors

Beijing VDJBio Co., LTD. (1)

Countries

China (1)